Literature DB >> 16330793

Pathogenesis of early lung disease in cystic fibrosis: a window of opportunity to eradicate bacteria.

Timothy D Starner1, Paul B McCray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330793     DOI: 10.7326/0003-4819-143-11-200512060-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  13 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Authors:  Amanda Plummer; Martin Wildman; Tim Gleeson
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

3.  Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  J Cyst Fibros       Date:  2019-04-26       Impact factor: 5.482

Review 4.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

5.  Airflow limitation following cardiopulmonary exercise testing and heavy-intensity intermittent exercise in children with cystic fibrosis.

Authors:  Daniel Stevens; Patrick J Oades; Craig A Williams
Journal:  Eur J Pediatr       Date:  2014-08-14       Impact factor: 3.183

6.  Nontypeable Haemophilus influenzae Infection Impedes Pseudomonas aeruginosa Colonization and Persistence in Mouse Respiratory Tract.

Authors:  Natalie R Lindgren; Lea Novak; Benjamin C Hunt; Melissa S McDaniel; W Edward Swords
Journal:  Infect Immun       Date:  2021-11-15       Impact factor: 3.609

7.  Adenoviral gene transfer corrects the ion transport defect in the sinus epithelia of a porcine CF model.

Authors:  Andrea E Potash; Tanner J Wallen; Philip H Karp; Sarah Ernst; Thomas O Moninger; Nicholas D Gansemer; David A Stoltz; Joseph Zabner; Eugene H Chang
Journal:  Mol Ther       Date:  2013-03-19       Impact factor: 11.454

8.  Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Authors:  Linsey Abbott; Amanda Plummer; Zhe Hui Hoo; Martin Wildman
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05

9.  Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease.

Authors:  Derek R Heimlich; Alistair Harrison; Kevin M Mason
Journal:  Antibiotics (Basel)       Date:  2014-12-01

10.  Molecular identification of Pseudomonas aeruginosa recovered from cystic fibrosis patients.

Authors:  M Douraghi; F Ghasemi; M M Soltan Dallal; M Rahbar; A Rahimiforoushani
Journal:  J Prev Med Hyg       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.